Office of Drug Control Policy
Office of Drug Control Policy to attend Midwestern Governors Association Regional Methamphetamine Summit

Press Release Date:  Tuesday, December 13, 2005  
Contact Information:  Contact Stacy Floden
(502) 564-8220
(502)-382-7155(Cell)
 


FRANKFORT, Ky– Kentucky’s Office of Drug Control Policy will be attending the Midwestern Governors Association Regional Methamphetamine Summit in Indianapolis, Indiana December 13-15.  This summit is being hosted by Indiana Governor Mitch Daniels and will be the first in a series of regional meth summits to be held in coordination with the White House Office of National Drug Control Policy.

This summit will allow Midwestern governors and key state decision makers to come together to discuss their experiences and innovative approaches to combating meth.  Participants will also hear from national and regional experts, and will have the opportunity to tour the Clean Lifestyle is Freedom Forever (CLIFF) Therapeutic Community of the Miami Correctional Facility which is a 240-bed meth treatment center in Bunker Hill, Indiana.

“Methamphetamine use and production was on the rise in Kentucky until the passage of Senate Bill 63 which limits the amount of precursor that can be purchased.  We have developed a multi-faceted approach to dealing with this in Kentucky by increasing law enforcement, treatment beds, and education/prevention efforts.  But the use of methamphetamine is one problem we must keep pressure on constantly and not surrender to,” said Teresa Barton, Executive Director of the Office of Drug Control Policy.  “This summit will allow states in our region to share ideas to curtail the meth problem in our country.  We will continue to work and coordinate as a state and a nation.”

Statewide, meth labs are at their lowest in Kentucky since 2001.  Thus far Kentucky has recognized an approximate 75% drop in meth labs since SB 63 went into effect on June 20, 2005.  Kentucky has a particular interest in bordering states that limit or schedule pseudo- ephedrine, especially Illinois and Ohio.

Meth use and production is a significant and complex problem in the Midwest.  According to a 2004 Drug Enforcement Agency Study, over 50% of all meth lab incidents in the United States occurred in the Midwest alone.